Table 2.
Transplantation outcomes.
| Donor type |
p | ||
|---|---|---|---|
| HAPLO (n = 49) | SIB (n = 42) | ||
| Granulocyte engraftment day | 11 (range 9–30) | 12 (range 8–35) | 0.9 |
| Platelet engraftment day | 15 (range 11–110) | 14 (range 10–125) | 0.9 |
| Acute GVHD grade 1–2/100 days | 28% | 24% | 0.4 |
| Acute GVHD grade 3–4/100 days | 4% | 5% | 0.9 |
| Mild chronic GVHD I–II/2 years | 35% | 32% | 0.5 |
| Severe chronic GVHD III/2 years | 8% | 8% | 0.9 |
| 3-year overall survival | 48% (95% CI 42–67) | 50% (95% CI 43–72) | 0.5 |
| 3-year overall mortality | 28% (95% CI 23–32) | 30% (95% CI 27–38) | 0.8 |
| 1-year transplant-related mortality | 10% | 14% | 0.8 |
| Relapse | 12% | 13% | 1 |